Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol

DUBLIN, April 2, 2019 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology company developing a new class of drugs known as DARPin® therapies, today announced topline safety results from...

from PR Newswire: https://ift.tt/2OHqzZN